Stage IVA Cervical Cancer Completed Phase 1 Trials for Cetuximab (DB00002)

IndicationStatusPhase
DBCOND0028785 (Stage IVA Cervical Cancer)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00104910Cetuximab, Cisplatin, and Radiation Therapy in Treating Patients With Stage IB, Stage II, Stage III, or Stage IVA Cervical CancerTreatment